Redeye: Imint - Tough 2024 ahead, but intriguing financial targets on the horizon
Redeye updates its estimates following Imint’s Q3 2023 report, which came in above our sales estimates, in part because of the timing of the lost revenues from a major Chinese customer. Imint conducted significant cost-savings during the quarter and provided new long-term financial goals.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/